Dolores L. Skarjune, who serves as the Executive Vice President and Chief Administrative Officer of Globe Life Inc., executed a significant transaction involving the company's equity on June 30, 2026. According to reported data, Skarjune sold 1,850 shares of Globe Life common stock, resulting in a total transaction value of $331,483. The shares were disposed of at a price of $179.18 per share. This sale was immediately preceded by the acquisition of an equal number of shares on the same day, which were obtained through the exercise of employee stock options. The acquisition of these 1,850 shares was executed at an exercise price of $103.23 per share, totaling $190,975. Following these transactions, Skarjune's direct holdings in Globe Life common stock stand at 13,696.734 shares. Additionally, she holds an indirect position of 2,899.424 shares through a 401(K) Plan.
The timing of this transaction is notable as Globe Life shares are currently trading near their 52-week high of $181.15. Over the past year, the stock has delivered a strong return of 45%. Despite this performance, analysis from InvestingPro suggests that the stock currently appears overvalued relative to its Fair Value. The platform offers 12 additional exclusive tips and comprehensive Pro Research Reports for GL and 1,400+ other US equities.
In the broader context of the company's recent performance, Globe Life Inc. reported its first-quarter 2026 earnings with a slight miss in earnings per share compared to forecasts. The company posted an EPS of $3.43, which fell just below the expected $3.48, representing a 1.44% negative surprise. However, revenue aligned with expectations, reaching $1.56 billion. Analyst updates following the report highlight varied but generally positive assessments. TD Cowen raised its price target for Globe Life to $215 from $199, maintaining a Buy rating and highlighting the company's attractive business model. Raymond James also increased its price target to $208 from $188, citing strong cash flow generation as a key factor. Meanwhile, BMO Capital adjusted its price target to $150 from $148, noting an increase in the midpoint of Globe Life's excess cash flow guidance. Truist Securities raised its price target to $185 from $180, reflecting an improved earnings per share estimate for 2026.
These developments underscore the continued interest and varied assessments from financial analysts regarding Globe Life's performance and prospects. The stock is currently trading at $179.97, up $0.72 or 0.40% in real-time data as of 12:57:31 USD. The company's financial metrics and executive activity continue to draw attention from market participants evaluating the insurance and financial services sector.